Clinical Trial Update: GSK706769 Repeat Dose Study [Phase 1]

View source ↗

Summary

Phase 1 repeat-dose study of GSK706769 in HIV infection completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GSK706769

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED